MedTrace Logo

Prevention of HCC Using Mobile Phone Applications

NCT05094869 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2021-10-26

No results posted yet for this study

Summary

This prospective cohort study is initiated to evaluate the compliance improvement to the standardized follow-up and clinical management in the population of compensatory hepatitis B cirrhosis with a mobile health application (APP). Patients were enrolled and divided into APP self-management group (APP only ) and APP intelligent-management group (APP and online interaction). The compliance to the standardized follow-up and clinical management (every six months) under the two clinical management modes would be evaluated and compared with the history data extracted from the platform of China Registry of Hepatitis B (CR-Hep B).

Conditions

Interventions

BEHAVIORAL

Use of mobile health application

The APP would regularly send messages including the medication reminder, health education knowledge, etc.

BEHAVIORAL

Online interaction

The patients would be able to upload their examination results in the APP and then the doctors will evaluate their disease progression every six months through the APP and guide patients' clinical practice accordingly.

BEHAVIORAL

Self follow-up reminders

The APP would regularly send messages including the follow-up reminder (manually set up by the patient on the APP)

BEHAVIORAL

Intelligent follow-up reminders

The APP would regularly send messages including the follow-up reminder (automatically set up by the APP)

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Jidong Jia, MD, PhD · Beijing Friendship Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05094869 on ClinicalTrials.gov